Immunoassay Analyzers: How They Work and What to Consider

Immunoassay analyzers are automated instruments that detect and quantify analytes such as hormones, antibodies, drugs, and proteins by using the specific binding between an antibody and its target antigen. These systems are central to clinical diagnostics, blood banking, therapeutic drug monitoring, and research applications. This article explains the core detection principles, workflow considerations, quality control requirements, and selection factors that laboratory students, technicians, researchers, and diagnostic professionals should understand before adopting or operating an immunoassay analyzer.

At a Glance

Immunoassay analyzers vary widely in throughput, detection technology, sample handling, and test menu breadth. The table below summarizes common analyzer categories and their distinguishing features.

Core Principles of Immunoassay Detection

Immunoassays exploit the highly specific recognition between antibodies and antigens. The analytical signal is generated by a label attached to one of the binding partners. The choice of label and detection method determines the sensitivity, dynamic range, and operational complexity of the system.

Competitive and Sandwich Formats

In a competitive immunoassay, the analyte in the sample competes with a labeled analyte for a limited number of antibody binding sites. The signal is inversely proportional to the analyte concentration. This format is commonly used for small molecules such as drugs, hormones, and antibiotics. Homogeneous enzyme immunoassays, which do not require separation of free and bound label, measure enzyme activity in the mixture of sample and reagents and are suitable for general-purpose automated clinical analyzers [8].

In a sandwich immunoassay, the analyte is captured between two antibodies, one immobilized on a solid phase and one carrying a detectable label. The signal is directly proportional to the analyte concentration. This format is preferred for larger molecules such as proteins, peptides, and antibodies. Sandwich assays generally offer higher sensitivity and specificity than competitive formats.

Label and Signal Detection Technologies

Electrochemiluminescence immunoassay (ECLIA) is a widely used detection principle in automated analyzers. The label emits light when stimulated electrochemically, and the signal is measured by a photodetector. A single-center study conducted on a Cobas e411 analyzer using ECLIA technology reported that among 453 SARS-CoV-2 antibody tests, 63.8% were reactive, 35.8% were non-reactive, and 0.4% were equivocal [6]. The same study noted that the highest number of reactive cases, 42.6%, occurred in individuals tested between 15 and 21 days after symptom onset [6]. This finding illustrates how detection timing relative to disease course affects result interpretation.

Chemiluminescence immunoassay (CLIA) uses chemical reactions to generate light without electrochemical stimulation. Automated chemiluminescence analyzers have been developed for high-throughput applications, and key technologies include precise reagent dispensing, reaction cell washing, and photomultiplier-based signal detection [25][26][27]. Portable chemiluminescence devices have also been commercialized for point-of-care and on-site testing, including allergy tests, flu tests, and cartridge-based immunoassay systems [12].

Fluorescence-based detection uses fluorophore labels excited by light of a specific wavelength. A portable analyzer designed for pouch-actuated immunoassay cassettes uses a compact scanner to excite fluorescence and detect emission from labels, with the analyzer hydraulically isolated from the cassette to reduce cross-contamination [20]. Fluorescent lateral flow immunoassays combined with desktop analyzers have been developed for rapid detection of biomarkers such as skeletal muscle troponin I, achieving a limit of detection of 0.5 ng/mL with a turnaround time of 15 minutes [19].

Agglutination and Turbidimetric Methods

Immunoagglutination assays measure the increase in turbidity or light scattering when antibody-antigen complexes form particles. Automated antistreptolysin O determinations use nephelometric immunoassay, latex agglutination photometric immunoassay, and turbidimetric immunoassay [7]. These methods correlate well with traditional semiquantitative tube dilution techniques, but quantitative accuracy decreases in regions of low and high antistreptolysin O values [7]. Standardization of automated measurements is necessary because methods vary between manufacturers [7].

Immunoturbidimetric assays can be implemented on open clinical chemistry analyzers. A canine-specific C-reactive protein assay evaluated on the ABX Pentra 400 analyzer demonstrated linearity from 4 to 281 mg/L, with recovery between 90% and 105% for clinically relevant concentrations [21]. The assay showed no interference up to 5 g/L hemoglobin, 800 mg/L bilirubin, and 10 g/L triglycerides, and no prozone effect occurred up to 676 mg/L C-reactive protein [21]. Method comparison against a reference assay revealed a Spearman correlation coefficient of 0.98 with a mean constant bias of 5.2% [21].

Analyzer Architecture and Workflow

Modern immunoassay analyzers integrate multiple functions into a single automated platform. Understanding the physical and operational components helps laboratory staff troubleshoot problems and optimize workflow.

Sample Handling and Transport

Analyzers accept samples in primary collection tubes, sample cups, or microtiter plates. The system identifies each sample through barcode reading and tracks its position through the analytical process. Sample probes aspirate a precise volume and dispense it into reaction vessels. Carryover prevention mechanisms include probe washing, disposable tips, and optimized fluidics.

Reagent Management

Reagents are stored onboard under temperature control. Each reagent pack contains antibodies, labeled conjugates, calibrators, and quality control materials specific to the assay. The analyzer monitors reagent volume, expiration dates, and onboard stability. Operators must load reagents according to manufacturer instructions and verify that the correct lot is matched to the calibration curve.

Reaction and Detection Modules

The reaction module controls incubation temperature, mixing, and timing. After the immunoreaction reaches equilibrium or a fixed endpoint, the detection module measures the signal. In ECLIA systems, the detection step involves electrochemical stimulation of the label and measurement of emitted light [6][11]. In fluorescence systems, the detection module excites the label and records emission intensity [20].

Data Processing and Result Reporting

The analyzer converts raw signal measurements into concentration values using a calibration curve. Results are transmitted to the laboratory information system for verification and reporting. Operators must review flags, delta checks, and quality control results before releasing patient results.

Assay Development and Validation Considerations

For laboratories that develop or modify immunoassays, validation is a critical step. The U.S. Food and Drug Administration provides guidance on bioanalytical method validation that covers accuracy, precision, selectivity, sensitivity, reproducibility, and stability [4]. The National Center for Advancing Translational Sciences Assay Guidance Manual offers detailed protocols for assay development and optimization [3].

Performance Characteristics to Evaluate

Precision is the closeness of agreement between repeated measurements. It is typically expressed as the coefficient of variation within a run and between runs. A study validating human chorionic gonadotropin measurement in cerebrospinal fluid using an electrochemiluminescence immunoassay reported intra-assay precision of 0.64% and 0.57% and inter-assay precision of 4.26% and 3.54% at two concentration levels [22].

The limit of quantitation is the lowest concentration that can be measured with acceptable precision and accuracy. The same cerebrospinal fluid study determined a limit of quantitation of 0.25 IU/L for human chorionic gonadotropin [22]. The analytical measurement range was established from 0.2 to 1,200 IU/L, and the reference interval for cerebrospinal fluid was below 0.40 IU/L [22].

Linearity and recovery assess whether the measured concentration is proportional to the true concentration across the analytical range. The canine C-reactive protein assay demonstrated linearity from 4 to 281 mg/L with recovery between 90% and 105% [21].

Matrix Effects and Alternative Sample Types

When an assay is used with a sample type other than the one for which it was validated, matrix effects can influence results. The College of American Pathologists accreditation requirements allow modified-approved methods, which are standard methods used outside their intended scope, provided they are properly validated [22]. A model for validating such methods includes evaluation of precision, limit of quantitation, analytical measurement range, and reference interval [22].

Reference Interval Establishment

Reference intervals must be established for each population and analyzer. A study establishing trimester-specific reference intervals for thyroid hormones in pregnant women used the CLSI EP28-A3c guideline and the Roche Cobas e411 analyzer [15]. The study included 401 healthy pregnant women and reported trimester-specific intervals for thyroid-stimulating hormone, free triiodothyronine, and free thyroxine [15]. Population-specific reference intervals are necessary because values vary across trimesters and geographic regions [15].

Quality Control and Assurance

Quality control is essential for reliable immunoassay results. The World Health Organization Laboratory Quality Management System Handbook provides a framework for implementing quality systems in medical laboratories [1].

Internal Quality Control

Internal quality control involves running control materials at defined intervals and comparing results against established ranges. Controls should cover low, normal, and high concentrations relevant to clinical decision points. Results are plotted on Levey-Jennings charts, and Westgard rules are applied to detect systematic or random errors.

External Quality Assessment

External quality assessment programs compare a laboratory's results with those of other laboratories using the same or different methods. Participation in these programs identifies method-specific biases and calibration drift. The World Health Organization handbook emphasizes the importance of external quality assessment as part of a comprehensive quality management system [1].

Calibration and Traceability

Calibration establishes the relationship between the measured signal and the analyte concentration. Calibrators are traceable to reference materials or reference methods. The analyzer must be recalibrated when reagent lots change, after major maintenance, or when quality control results indicate drift.

Verification of Analyzer Performance

Before placing an analyzer into routine service, laboratories should verify that the instrument meets the manufacturer's claimed performance specifications. Verification includes precision studies, accuracy comparisons, and linearity assessments. A study comparing the analytical performance of autoimmune antibody measurements on two different automated immunoassay analyzers found good compliance for 16 of 21 compared parameters, with discrepancies observed for celiac and rheumatoid parameters [17]. This finding underscores the importance of method comparison studies when introducing a new analyzer.

Selecting an Immunoassay Analyzer

The choice of analyzer depends on the laboratory's test volume, test menu requirements, available space, budget, and staffing. Several factors should be evaluated systematically.

Throughput and Turnaround Time

Throughput is the number of tests the analyzer can process per hour. High-throughput systems are designed for large laboratories with high test volumes. A review of high-throughput coagulation analyzers noted that the increasing number of ordered screening tests led to improved efficiency in automated testing and the appearance of analyzers that simultaneously use clotting, chromogenic, and immunological principles [10]. These systems reduce strain and human error while maximizing productivity [10].

Test Menu and Flexibility

The analyzer should support the laboratory's current and anticipated test menu. Some systems offer a broad menu including hormones, tumor markers, cardiac markers, infectious disease serology, and therapeutic drug monitoring. Open systems allow the use of reagents from multiple manufacturers, while closed systems restrict reagents to the analyzer vendor.

Sample Types and Volume

Consider whether the analyzer accepts serum, plasma, whole blood, urine, cerebrospinal fluid, or other sample types. The minimum sample volume per test affects the ability to run multiple tests on limited samples, such as pediatric or veterinary specimens.

Connectivity and Automation

Integration with laboratory information systems, track systems, and pre-analytical automation improves workflow efficiency. The analyzer should support bidirectional communication for test ordering and result reporting.

Cost of Ownership

The total cost includes the initial purchase price, reagent costs, consumables, maintenance contracts, and service. Reagent costs are often the dominant ongoing expense. Laboratories should calculate the cost per test for their specific test mix.

Space and Utility Requirements

Benchtop analyzers require less floor space than modular systems. Consider the analyzer's dimensions, weight, power requirements, water supply, and waste disposal needs. The World Health Organization Laboratory Biosafety Manual provides guidance on facility design and biosafety considerations for laboratories [2].

Practical Implementation Steps

Implementing a new immunoassay analyzer requires a structured approach to ensure reliable performance and staff competency.

Step 1: Define Requirements

Document the laboratory's test volume, test menu, turnaround time targets, and available resources. Involve stakeholders from clinical, technical, and administrative areas in the selection process.

Step 2: Evaluate Candidate Analyzers

Request demonstrations and conduct side-by-side evaluations using the laboratory's routine samples. Compare precision, accuracy, throughput, and ease of use. Assess the vendor's service response time and technical support.

Step 3: Perform Verification Studies

Before routine use, verify the analyzer's performance using the manufacturer's protocols or the laboratory's validation procedures. Include precision, accuracy, linearity, and method comparison studies. Document all results.

Step 4: Train Staff

Provide comprehensive training on analyzer operation, maintenance, quality control, and troubleshooting. Assess competency through written tests and observed performance.

Step 5: Establish Quality Control Procedures

Define the frequency of quality control testing, the control levels to be used, and the rules for accepting or rejecting runs. Establish procedures for investigating and documenting quality control failures.

Step 6: Monitor Performance

Continuously monitor quality control results, turnaround times, and error rates. Review performance indicators at regular intervals and implement corrective actions when needed.

Records and Measurements

Accurate record keeping is essential for regulatory compliance and quality improvement. The World Health Organization Laboratory Quality Management System Handbook emphasizes the importance of documentation in laboratory operations [1].

Required Records

Maintain records of analyzer maintenance, calibration, quality control results, and corrective actions. Document reagent lot numbers, expiration dates, and receipt dates. Record temperature monitoring for reagent storage and analyzer operation.

Performance Metrics

Track the following metrics to assess analyzer performance:

Documentation of Troubleshooting

When problems occur, document the issue, the investigation, the corrective action, and the outcome. This documentation supports continuous improvement and provides evidence of due diligence during inspections.

Common Failure Patterns and Troubleshooting

Understanding common failure modes helps laboratory staff identify and resolve problems quickly.

Calibration Failures

Calibration failures occur when the analyzer cannot establish an acceptable calibration curve. Possible causes include expired or degraded reagents, incorrect reagent storage, instrument malfunction, or matrix effects in the calibrator. Verify reagent integrity, repeat the calibration, and contact the manufacturer if the problem persists.

Quality Control Out-of-Range Results

Quality control results outside the established range indicate a problem with the assay system. Investigate reagent lot changes, calibration status, instrument maintenance, and control material handling. Repeat the test with fresh controls before accepting or rejecting the run.

Carryover Contamination

Carryover occurs when a high-concentration sample contaminates a subsequent sample. This problem is more likely with high-sensitivity assays. The analyzer's wash protocols and disposable tips are designed to minimize carryover. Portable analyzers that are hydraulically isolated from the cassette reduce the possibility of cross-contamination [20].

Prozone or Hook Effect

The prozone effect occurs when very high analyte concentrations saturate the antibody binding sites, causing a falsely low signal. The canine C-reactive protein assay showed no prozone effect up to 676 mg/L [21]. Laboratories should be aware of this limitation and use dilution protocols when the clinical presentation suggests very high analyte levels.

Interference from Endogenous Substances

Hemoglobin, bilirubin, triglycerides, and other substances can interfere with immunoassay measurements. The canine C-reactive protein assay showed no interference up to 5 g/L hemoglobin, 800 mg/L bilirubin, and 10 g/L triglycerides [21]. Laboratories should document the interference limits for each assay and flag results from hemolyzed, icteric, or lipemic samples.

Sample Matrix Issues

Alternative sample types such as cerebrospinal fluid, urine, or heparinized plasma may produce matrix effects. A study evaluating the impact of sample type on canine C-reactive protein results found a statistically significant but clinically not relevant difference between serum and lithium heparin plasma [21]. Laboratories must validate each sample type before routine use.

Limitations and Interpretation Cautions

Immunoassay results must be interpreted in the context of the assay's limitations and the patient's clinical presentation.

Timing of Antibody Detection

The timing of sample collection relative to symptom onset affects antibody detection. In a study of SARS-CoV-2 antibody testing, the highest number of reactive cases occurred in individuals tested between 15 and 21 days after symptom onset [6][11]. Early samples may be non-reactive even in infected individuals, and late samples may show declining antibody levels.

Assay-Specific Differences

Different immunoassay platforms may produce different results for the same analyte. A comparison of autoimmune antibody measurements on two automated analyzers found good compliance for most parameters but discrepancies for celiac and rheumatoid parameters [17]. Laboratories should be aware of these differences when interpreting results from different platforms.

Quantitative Accuracy at Extremes

Automated immunoagglutination assays show decreased quantitative accuracy in regions of low and high analyte values [7]. Results near the lower or upper limits of the analytical range should be interpreted with caution and confirmed by alternative methods when clinically indicated.

Reference Interval Applicability

Reference intervals are population-specific and may not apply to different demographic groups or geographic regions. The trimester-specific reference intervals for thyroid hormones established in pregnant women in Algeria demonstrate the need for population-specific values [15]. Laboratories should verify that the reference intervals they use are appropriate for their patient population.

Point-of-Care Testing Limitations

Point-of-care immunoassay devices offer portability and rapid results but may have lower sensitivity and precision than laboratory-based analyzers. A portable analyzer for pouch-actuated immunoassay cassettes reduces the level of expertise required from the operator and the possibility for errors [20]. However, users must follow the manufacturer's instructions and perform quality control as specified.

Biosafety and Laboratory Safety

Immunoassay analyzers process biological samples that may contain infectious agents. The World Health Organization Laboratory Biosafety Manual provides guidance on safe handling of biological materials and laboratory design [2].

Personal Protective Equipment

Laboratory staff must wear appropriate personal protective equipment, including gloves, laboratory coats, and eye protection when handling samples and reagents. The biosafety manual emphasizes the importance of standard precautions for all patient samples [2].

Waste Management

Sample cups, reaction vessels, and other consumables that contact biological samples must be disposed of as biohazardous waste. The analyzer's waste system should be maintained according to the manufacturer's instructions to prevent spills and contamination.

Spill Response

Laboratories must have procedures for cleaning up biological spills. The World Health Organization Laboratory Biosafety Manual provides guidance on decontamination and spill response [2]. Staff should be trained on these procedures and the location of spill kits.

Instrument Maintenance and Decontamination

Regular maintenance reduces the risk of instrument malfunction and contamination. The analyzer's probes, wash stations, and waste lines should be cleaned according to the manufacturer's schedule. Decontamination procedures should be performed before service or repair.

Professional Escalation Criteria

Laboratory professionals should escalate issues to supervisors, manufacturers, or regulatory authorities under specific circumstances.

Escalate to the Laboratory Supervisor When

• Quality control results consistently fail despite corrective action
• The analyzer produces results that do not correlate with the patient's clinical presentation
• Calibration failures persist after repeating the procedure
• The analyzer requires repair or replacement of major components
• Staff competency issues are identified during training or assessment

Escalate to the Manufacturer When

• The analyzer exhibits a recurring error that cannot be resolved through routine troubleshooting
• Reagent lots produce unexpected results across multiple laboratories
• The instrument's performance does not meet the manufacturer's specifications
• Software or firmware issues affect result accuracy or data integrity

Escalate to Regulatory Authorities When

• Results are suspected to have caused patient harm
• The analyzer or reagents are suspected of being defective or unsafe
• There is evidence of fraud or intentional misrepresentation of results
• The laboratory is unable to resolve a critical quality issue that affects patient safety

Frequently Asked Questions

What is an immunoassay test?

An immunoassay test is a laboratory method that uses the specific binding between an antibody and an antigen to detect or quantify a substance in a biological sample. The substance being measured, called the analyte, can be a hormone, drug, protein, antibody, or other molecule. Immunoassays are used for a wide range of clinical and research applications, including infectious disease serology, therapeutic drug monitoring, and biomarker measurement.

What is an immunoassay test for drugs?

An immunoassay test for drugs detects the presence of specific drugs or their metabolites in biological samples such as urine, blood, or saliva. These tests are commonly used for workplace drug screening, clinical toxicology, and monitoring of therapeutic drug levels. Homogeneous enzyme immunoassays, which do not require separation of free and bound label, are suitable for measuring drug concentrations on general-purpose automated clinical analyzers [8].

What does immunoassay mean?

Immunoassay means a biochemical test that measures the presence or concentration of a substance through the reaction of an antibody to its antigen. The term combines "immuno," referring to the immune system components involved, and "assay," meaning a quantitative or qualitative test. The assay uses a labeled antibody or antigen to generate a measurable signal that is proportional to the analyte concentration.

How does an electrochemiluminescence immunoassay work?

An electrochemiluminescence immunoassay uses a label that emits light when stimulated electrochemically. The analyte is captured in a sandwich or competitive format, and the labeled complex is brought to an electrode surface where the electrochemical reaction triggers light emission. The light intensity is measured by a photodetector and converted to a concentration value using a calibration curve. This principle is used in analyzers such as the Cobas e411 and Cobas e601 systems [6][11][23].

What factors should be considered when choosing an immunoassay analyzer?

Key factors include test volume and throughput requirements, the test menu needed, sample types accepted, available space, budget, and staffing. Laboratories should also evaluate the analyzer's precision, accuracy, calibration stability, and ease of use. The cost of reagents and consumables is often the dominant ongoing expense. Method comparison studies should be performed to verify that the new analyzer produces results consistent with the laboratory's current methods [17].

How often should an immunoassay analyzer be calibrated?

Calibration frequency depends on the manufacturer's recommendations, reagent lot changes, and quality control results. The analyzer should be recalibrated when a new reagent lot is opened, after major maintenance, or when quality control results indicate drift. Some analyzers require calibration at defined intervals even when reagent lots do not change. Laboratories should follow the manufacturer's instructions and document all calibrations.

What is the prozone effect in immunoassays?

The prozone effect, also called the hook effect, occurs when very high analyte concentrations saturate the antibody binding sites and cause a falsely low signal. This effect is more common in sandwich immunoassays and can lead to incorrect results for samples with extremely high analyte levels. Laboratories should be aware of the prozone limits for each assay and use dilution protocols when the clinical presentation suggests very high analyte concentrations [21].

How are reference intervals established for immunoassay tests?

Reference intervals are established by measuring the analyte in a healthy reference population and calculating the central 95% interval, typically the 2.5th and 97.5th percentiles. The CLSI EP28-A3c guideline provides a standardized approach for this process [15]. Reference intervals are population-specific and may vary by age, sex, pregnancy status, and geographic region. Laboratories should verify that the reference intervals they use are appropriate for their patient population [15].

Related Diagnostic Guides

• Affinity Chromatography for Protein Purification: Principles and Column Selection
• Comparison of Southern, Northern, and Western Blotting: Principles and Applications
• Understanding Ct Values in qPCR: What They Mean and How to Use Them
• DNA Extraction from Hair Follicles: Protocol for Forensic and Research Use
• Thermometer Calibration for Laboratory Use: Ice Point and Comparison Methods

References and Further Reading

• Laboratory Quality Management System Handbook. World Health Organization.
• Laboratory Biosafety Manual. World Health Organization.
• Assay Guidance Manual. National Center for Advancing Translational Sciences.
• Bioanalytical Method Validation Guidance. U.S. Food and Drug Administration.
• NCBI Literature Resources. National Center for Biotechnology Information.
• A Single-centre Study of COVID-19 Antibody.. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2021.
• [Antistreptolysin O].. Rinsho byori. The Japanese journal of clinical pathology, 1992.
• [B/F non-separative method].. Nihon rinsho. Japanese journal of clinical medicine, 1995.
• Evaluation of artificial intelligence-assisted morphological analysis for platelet count estimation.. International journal of laboratory hematology, 2024.
• High throughput coagulation analyzers review.. Combinatorial chemistry & high throughput screening, 2005.
• A Single-centre Study of COVID-19 Antibody.. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2021.
• Prospects for the commercialization of chemiluminescence-based point-of-care and on-site testing devices.. Analytical and bioanalytical chemistry, 2014.
• Sensors and Analytical Technologies for Air Quality: Particulate Matters and Bioaerosols.. Chemistry, an Asian journal, 2020.
• Demonstrating Clinical Performance of the Elecsys Anti-SARS-CoV-2 Anti-Nucleocapsid Immunoassay Using Real-World Data to Support Regulatory Decision-Making in the USA.. 2026.
• Establishment of Trimester-Specific Reference Intervals for TSH and Thyroid Hormones in Pregnant Women living in Oran, Western Algeria.. 2026.
• Early Detection of Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage by IL-6 Electrochemiluminescence Analysis of the Cerebrospinal Fluid.. 2026.
• CONCORDANCE OF THE ANALYTICAL PERFORMANCE OF AUTOIMMUNE ANTIBODIES ON THE HOB BIOCLIA® 1200 AUTOMATED IMMUNOASSAY ANALYZER TO THE PHADIA 250® SYSTEM. 2019.
• Carbon nanospheres dual spectral-overlapped fluorescence quenching lateral flow immunoassay for rapid diagnosis of toxoplasmosis in humans.. Journal of Pharmaceutical and Biomedical Analysis, 2024.
• A Fluorescent Lateral Flow Immunoassay for the Detection of Skeletal Muscle Troponin I in Serum for Muscle Injury Monitoring at the Point of Care. Biosensors, 2024.
• A Portable Analyzer for Pouch-Actuated, Immunoassay Cassettes. Sensors and actuators. B, Chemical, 2011.
• Evaluation of a species-specific C-reactive protein assay for the dog on the ABX Pentra 400 clinical chemistry analyzer. BMC Veterinary Research, 2017.
• An Immunoassay for Human Chorionic Gonadotropin in Cerebrospinal Fluid: Validation of a Modified-Approved Method for Accreditation by the College of American Pathologists. Journal of Laboratory Physicians, 2021.
• Nucleic Acid Amplification Testing for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus in Blood Donors at a Tertiary Care Hospital Blood Bank. Cureus, 2025.
• Portable quantitative fluorescence immunoassay analyzer. Applied Mechanics and Materials, 2013.
• Key technologies of chemiluminescence immunoassay analyzer. Faguang Xuebao Chinese Journal of Luminescence, 2012.
• Development of high flux immunoassay analyzer based on chemiluminescence. Yi Qi Yi Biao Xue Bao Chinese Journal of Scientific Instrument, 2013.
• Automated chemiluminescence immunoassay analyzer. 2010 International Conference on Intelligent Computation Technology and Automation Icicta 2010, 2010.
• A small automated enzyme immunoassay analyzer system design and implementation based on immunoenzymatic techniques. Key Engineering Materials, 2016.
• Chemiluminescence immunoassay analyzer control system based on S3C2410A. Applied Mechanics and Materials, 2012.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.